paromomycin has been researched along with Communicable Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calado, S; Castro, H; Correia, I; Cruz, ME; Ferronha, H; Gaspar, MM; Pereira, J; Tomás, AM | 1 |
| Hu, LT; Klempner, MS; Unnasch, TR | 1 |
2 other study(ies) available for paromomycin and Communicable Diseases
| Article | Year |
|---|---|
Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems.
Topics: Animals; Communicable Diseases; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Humans; Leishmania; Lipids; Liposomes; Mice; Mycobacterium; Paromomycin; Tissue Distribution | 2015 |
Taking a bite out of vector-transmitted infectious diseases.
Topics: Animals; Antiprotozoal Agents; Communicable Disease Control; Communicable Diseases; Disease Reservoirs; Disease Transmission, Infectious; Disease Vectors; Humans; Leishmaniasis, Visceral; Paromomycin; Psychodidae; Vaccines | 2007 |